PKG00283572.docx

This is an application submission document designated for Type 6 applications under RFA-OE-18-000, a cooperative agreement opportunity from the Centers for Disease Control and Prevention (CDC) focusing on Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). The application deadline has been extended to September 30, 2030. Eligible applicants include U.S. state governments, territorial governments, political subdivisions, universities, counties, small businesses, and non-profit organizations, with only one application funded per state or territory. Applicants must demonstrate access to state or territory-wide data sources and provide documentation of governmental affiliation if applying as a bona fide agent.

Awards provide financial assistance for 12-month budget periods with performance periods of up to five years, contingent on fund availability and satisfactory recipient progress. Typical award values range from $100,000 to $700,000 annually, with cooperative agreements typically between $350,000 and $1.4 million. Applications undergo a two-phase review process: Phase 1 screens for eligibility and completeness, while Phase 2 evaluates approach, evaluation and performance measurement capabilities, and organizational capacity to implement the proposed strategy. Recipients must comply with a mandatory three-year record retention requirement and are subject to inspections and audits by the Department of Health and Human Services. The program supports development, implementation, and promotion of evidence-based injury and violence prevention practices across multiple domains including child abuse prevention, sexual violence prevention, firearm-related violence reduction, and overdose prevention.